132 related articles for article (PubMed ID: 30568828)
1. Incidence and Antifungal Susceptibility of Candida Albicans Infections.
Ungureanu A; Gaman AE; Turculeanu A; Mitroi M; Drocas AI; Dobritoiu M; Alexandru DO; Vasile C
Curr Health Sci J; 2016; 42(2):164-168. PubMed ID: 30568828
[TBL] [Abstract][Full Text] [Related]
2. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of resistance and sensitivity of 1 200 strains of vulvovaginal candidiasis in China to five common antifungal drugs].
Fan LY; Liu ZH; Bai XN; Zong X
Zhonghua Fu Chan Ke Za Zhi; 2022 Aug; 57(8):601-607. PubMed ID: 36008287
[No Abstract] [Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.
Anh DN; Hung DN; Tien TV; Dinh VN; Son VT; Luong NV; Van NT; Quynh NTN; Van Tuan N; Tuan LQ; Bac ND; Luc NK; Anh LT; Trung DM
BMC Infect Dis; 2021 Jun; 21(1):523. PubMed ID: 34082699
[TBL] [Abstract][Full Text] [Related]
8. Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis.
Tamai IA; Pakbin B; Fasaei BN
BMC Res Notes; 2021 Mar; 14(1):93. PubMed ID: 33691787
[TBL] [Abstract][Full Text] [Related]
9. Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal.
Khadka S; Sherchand JB; Pokhrel BM; Parajuli K; Mishra SK; Sharma S; Shah N; Kattel HP; Dhital S; Khatiwada S; Parajuli N; Pradhan M; Rijal BP
BMC Res Notes; 2017 Jun; 10(1):218. PubMed ID: 28646915
[TBL] [Abstract][Full Text] [Related]
10. Biofilm-Producing
Lamichhane K; Adhikari N; Bastola A; Devkota L; Bhandari P; Dhungel B; Thapa Shrestha U; Adhikari B; Banjara MR; Rijal KR; Ghimire P
HIV AIDS (Auckl); 2020; 12():211-220. PubMed ID: 32606995
[TBL] [Abstract][Full Text] [Related]
11. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
12. In-vitro evaluation of virulence markers and antifungal resistance of clinical Candida albicans strains isolated from Karachi, Pakistan.
Jabeen G; Naz SA; Rangel DEN; Jabeen N; Shafique M; Yasmeen K
Fungal Biol; 2023; 127(7-8):1241-1249. PubMed ID: 37495314
[TBL] [Abstract][Full Text] [Related]
13. Candidiasis in Birds (Galliformes, Anseriformes, Psittaciformes, Passeriformes, and Columbiformes): A Focus on Antifungal Susceptibility Pattern of Candida albicans and Non-albicans Isolates in Avian Clinical Specimens.
Talazadeh F; Ghorbanpoor M; Shahriyari A
Top Companion Anim Med; 2022; 46():100598. PubMed ID: 34700027
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
Khan F; Baqai R
J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
[TBL] [Abstract][Full Text] [Related]
16. Candiduria in children and susceptibility patterns of recovered Candida species to antifungal drugs in Ahvaz.
Seifi Z; Azish M; Salehi Z; Zarei Mahmoudabadi A; Shamsizadeh A
J Nephropathol; 2013 Apr; 2(2):122-8. PubMed ID: 24475438
[TBL] [Abstract][Full Text] [Related]
17.
Njunda AL; Nsagha DS; Assob JC; Kamga HL; Teyim P
J Public Health Afr; 2012 Mar; 3(1):e2. PubMed ID: 28299076
[TBL] [Abstract][Full Text] [Related]
18. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
Liu XP; Fan SR; Peng YT; Zhang HP
J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and antifungal susceptibility of
Bhattacharjee P
Curr Med Mycol; 2016 Jun; 2(2):20-27. PubMed ID: 28681016
[TBL] [Abstract][Full Text] [Related]
20. Fungal Profile of Vulvovaginal Candidiasis in a Tertiary Care Hospital.
Kalaiarasan K; Singh R; Chaturvedula L
J Clin Diagn Res; 2017 Mar; 11(3):DC06-DC09. PubMed ID: 28511380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]